(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.

Original source: https://www.eurekalert.org/pub_releases/2019-04/tkai-ods041919.php